Validation and comparison of diagnostic accuracy of four screening tools for mental disorders in people seeking treatment for substance use disorders

Journal of Substance Abuse Treatment

Volumn 44, Issue 4, 2013, Pages 375-383

  Rush, Brian ^a,b   Castel, Saulo ^b,c   Brands, Bruna ^a,b,d   Toneatto, Tony ^b   Veldhuizen, Scott ^a  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c ONTARIO SHORES CENTRE FOR MENTAL HEALTH SCIENCES   (Canada)

^d HEALTH CANADA   (Canada)

Author keywords

Addiction; Concurrent disorders; Mental health; Mood and anxiety; Screening; Substance abuse

Indexed keywords

ADDICTION SEVERITY INDEX; ADULT; AGORAPHOBIA; ALCOHOL ABUSE; ANXIETY DISORDER; ARTICLE; COMPARATIVE EFFECTIVENESS; DEPRESSION; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DRUG ABUSE; DRUG DEPENDENCE TREATMENT; EATING DISORDER; FEMALE; GENERALIZED ANXIETY DISORDER; HELP SEEKING BEHAVIOR; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MOOD DISORDER; OBSESSIVE COMPULSIVE DISORDER; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHIATRIC DIAGNOSIS; PSYCHOSIS; QUALITATIVE VALIDITY; SOCIAL PHOBIA; SOMATOFORM DISORDER; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; SUBSTANCE ABUSE; TREATMENT PLANNING;

ADOLESCENT; ADULT; ALCOHOLISM; AREA UNDER CURVE; BREATH TESTS; COGNITION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMANS; MALE; MARITAL STATUS; MENTAL DISORDERS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT SELECTION; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; ROC CURVE; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 84873749588     PISSN: 07405472     EISSN: 18736483     Source Type: Journal    
DOI: 10.1016/j.jsat.2012.08.221     Document Type: Article

References (48)

1. Diagnostic and statistical manual of mental disorders (DSM-IV) 1994, American Psychiatric Association, American Psychiatric Association Press, Washington, D.C.
2. Barnaby B., Drummond C., McCloud A., Burns T., Omu N. Substance misuse in psychiatric inpatients: Comparison of a screening questionnaire survey with case notes. British Medical Journal 2003, 327:783-784.
3. Bossuyt P.M., Reitsma J.B., Bruns D.E., Gatsonis C.A., Glasziou P.P., Irwig L.M., et al. Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative. Clinical Chemistry 2003, 49:1-6.
4. Bossuyt P.M., Reitsma J.B., Bruns D.E., Gatsonis C.A., Glasziou P.P., Irwig L.M., et al. The STARD statement for reporting studies of diagnostic accuracy: Explanation and elaboration. Clinical Chemistry 2003, 49:7-18.
5. Cacciola J.S., Pecoraro A., Alterman A.I. Development of ASI psychiatric severity cut-off scores to identify co-occurring psychiatric disorders. International Journal of Mental Health and Addiction 2008, 6:77-92.
6. Castel S., Rush B.R., Scalco M. Screening for mental disorders among clients with addictions: The need for population-specific validation. International Journal of Mental Health and Addiction 2008, 6:64-71.
7. Center for Substance Abuse Treatment Substance Abuse Treatment for Persons With Co-Occurring Disorders. Treatment Improvement Protocol (TIP) Series 42. DHHS Publication No. (SMA) 05-3922 2005, Substance Abuse and Mental Health Services Administration, Rockville, MD.
8. Chan Y.F., Dennis M.L., Funk R.R. Prevalence and comorbidity co-occurrence of major internalizing and externalizing disorders among adolescents and adults presenting to substance abuse treatment. Journal of Substance Abuse Treatment 2008, 34:14-24.
9. Clark R.E., Samnaliev M., McGovern M. Treatment for co-occurring mental and substance use disorders in five state Medicaid programs. Psychiatric Services 2007, 58:942-948.
10. Dennis M., Chan Y.F., Funk R. Development and validation of the GAIN Short Screener (GSS) for internalizing, externalizing and substance use disorders and crime/violence problems among adolescents and adults. The American Journal on Addictions 2006, 15:80-91.
11. Department of Health, & Services, Human Substance Abuse and Mental Health Services Administration. Report to Congress on the prevention and treatment of co-occurring substance abuse disorders and mental disorders 2002, Department of Health and Human Services, Washington (DC).
12. Dickey B., Azeni H. Persons with dual diagnosis of substance abuse and major mental illness: Their excess costs of psychiatric care. American Journal of Public Health 1996, 86:973-977.
13. Drug and Alcohol Treatment Information System. (2011, April 11). Retrieved from http://www.DATIS.ca.
14. Druss B.G., Wang P.S., Sampson N.A., Olfson M., Pincus H.A., Wells K.B., Kessler R.C. Understanding mental health treatment in persons without medical diagnoses. Archives of General Psychiatry 2007, 64:1196-1203.
15. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition. (SCID-I/P) 2002, Biometrics Research, New York State Psychiatric Institute, New York.
16. Fischer J.E., Bachmann L.M., Jaeschke R. A readers' guide to the interpretration of diagnostic test properties: clinical example of sepsis. Intensive Care Medicine 2003, 29:1043-1051.
17. Fixsen D.L., Naoom S.F., Blasé K.A., Friedman R.M., Wallace F. Implementation research: A synthesis of the literature 2005, University of South Florida, Louis de la Parte Florida Mental Health Institute, The National Implementation Research Network (FMHI Publication #231), Tampa, Florida.
18. Flynn P.M., Brown B.S. Co-occurring disorders in substance abuse treatment: Issues and prospects. Journal of Substance Abuse Treatment 2008, 34:36-47.
19. GAIN Coordinating Centre. (2010, November 3). GCC Insider: The GAIN Coordinating Centre Newsletter. Issue 9, Summer 2010. Retrieved from http://www.chestnut.org/li/gain/GCC_Insider/.
20. Grove W., Meehl P. Comparative efficacy of informal (subjective, impressionistic) and formal (mechanical, algorithmic) prediction procedures: The clinical-statistical controversy. Psychology, Public Policy, and Law 1996, 2:293-323.
21. Health Canada Best practice for concurrent mental health and substance use disorders. (Cat. No. H39-599/2001-2E/ISBN: 0-662-31388-7 2001, Health Canada, Ottawa.
22. Katzman R., Brown T., Fuld P., Peck A., Schechter R., Schimmel H. Validation of a short Orientation-Memory-Concentration Test of cognitive impairment. The American Journal of Psychiatry 1983, 140:734-739.
23. Kessler R.C., Andrews G., Colpe L.J., Hiripi E., Mroczek D.K., Normand S.-L.T., et al. Short screening scales to monitor population prevalences and trends in non-specific psychological distress. Psychological Medicine 2002, 32:959-976.
24. Kessler R.C., Barker P.R., Colpe L.J., Epstein J.F., Gfroerer J.C., Hiripi E., et al. Screening for serious mental illness in the general population. Archives of General Psychiatry 2003, 60:184-189.
25. Kessler R.G., Green J.G., Gruber M.J., Sampson N.A., Bromet E., Cuitan M., et al. Screening for serious mental illness in the general population with the K6 screening scales: Results from the WHO World Mental Health (WMH) survey initiative. International Journal of Methods in Psychiatric Research 2010, 19(supplement 1):4-22.
26. Krishnan K.R. Psychiatric and medical comorbidities of bipolar disorder. Psychosomatic Medicine 2005, 67:1-8.
27. Lucenko B.A., Mancuso D., Felver B.E.M., Yakup S. Co-occurring mental illness among clients in chemical dependency treatment 2010, Washington State Department of Social and Health Services Research and Data Analysis Division, Olympia, WA, Retrieved from http://www.dshs.wa.gov//pdf/ms/rda/research/4/82.pdf.
28. Lasko T.A., Bhagwat J.G., Zou K.H., Ohno-Machado L. The use of receiver operating characteristic curves in biomedical informatics. Journal of Biomedical Informatics 2005, 38:404-415.
29. McDonnell M.G., Comtois K.A., Voss W.D., Morgan A.G., Ries R.K. Global Appraisal of Individual Needs Short Screener (GSS): Psychometric properties and performance as a screening measure in adolescents. The American Journal of Drug and Alcohol Abuse 2009, 35:157-160.
30. McLellan A.T., Kushner H., Metzger D., Peters R., Smith I., Grissom G. The fifth edition of the addiction severity index. Journal of Substance Abuse Treatment 1992, 9:199-213.
31. McLellan A.T., Luborsky L., Woody G., O'Brien C.P., Druley K.A. Predicting response to alcohol and drug treatments: Role of psychiatric severity. Archives of General Psychiatry 1983, 40:620-625.
32. Parikh S. Screening and treating mental disorders in addiction treatment settings: A stepped care model. International Journal of Mental Health and Addiction 2008, 6:137-140.
33. Rotondi, N., & Rush, B. R. (in press). Monitoring utilization of a large scale addiction treatment system: The Drug and Alcohol Treatment Information System (DATIS). Substance Abuse: Research and Treatment.
34. Rush B.R., Castel S. Screening for mental and substance use disorders. Care in Mental Health-Substance Use. Book 5, Chapter 8 2011, 89-105. Mental Health-Substance Use Book Series: Radcliffe Publishing Ltd., Oxford, UK. D. Cooper (Ed.).
35. Rush B.R., Nadeau L. On the integration of mental health and substance use services and systems. Responding in Mental Health-Substance Use. Book 3, Chapter 13 2011, 148-175. Mental Health-Substance Use Book Series: Radcliffe Publishing Ltd, Oxford UK. D. Cooper (Ed.).
36. Rush B.R., Castel S., Brands B., Toneatto T. Validation and comparison of screening tools for mental disorders in substance abusers 2008.
37. Sacks S. Brief overview of screening and assessment for co-occurring disorders. International Journal of Mental Health and Addiction 2008, 6:7-19.
38. Sobell L.C., Sobell M.B. Self-report issues in alcohol abuse: State of the art & future. Behavioural Assessment 1990, 12:77-90.
39. StataCorp. Stata Statistical Software: Release 9 2005, StataCorp LP, College Station, TX.
40. Streiner D.L., Cairney J. What's under the ROC? An introduction to receiver operating characteristics curves. Canadian Journal of Psychiatry 2007, 52:121-128.
41. Swets J.A. Measuring the accuracy of diagnostic systems. Science 1988, 240:1285-1293.
42. Swets J.A., Dawes R.M., Monahan J. Psychological science can improve diagnostic decisions. Psychological Science in the Public Interest 2000, 1-26.
43. Swartz J.A. Using the K6 scale to screen for serious mental illness among criminal justice populations: Do psychiatric treatment indicators improve detection rates?. International Journal of Mental Health and Addiction 2008, 6:93-104.
44. Swartz J.A., Lurigio A.J. Screening for serious mental illness in populations with co-occurring substance use disorders: Performance of the K6 scale. Journal of Substance Abuse Treatment 2006, 31:287-296.
45. Wilkinson D.A., Leigh G.M., Cordingley J., Martin G.W., Lei H. Dimensions of multiple drug use and a typology of drug users. British Journal of Addiction 1987, 82:259-273.
46. Zimmerman M., Mattia J.I. Psychiatric diagnosis in clinical practice: Is comorbidity being missed?. Comprehensive Psychiatry 1999, 40:182-191.
47. Zimmerman M., Mattia J.I. The psychiatric diagnostic screening questionnaire: Development, reliability and validity. Comprehensive Psychiatry 2001, 42:175-189.
48. Zimmerman M., Sheeran T., Chelminski I., Young D. Screening for psychiatric disorders in outpatients with DSM-IV substance use disorders. Journal of Substance Abuse Treatment 2004, 26:181-188.